A novel mouse model of hemangiopericytoma due to loss of Tsc2. | Academic Article individual record
abstract

Hemangiopericytoma (HPC) is a rare vascular tumor, which is thought to originate from pericytes. However, no direct evidence for the cell of origin has been found, and the mechanism of HPC tumorigenesis is poorly understood. Here we report that loss of the tumor suppressor gene Tsc2 in pericytes using a FoxD1 promoter driven cre allele (Foxd1tm1(GFP/cre) Amc, FoxD1GC) leads to the formation of HPC in multiple sites. Tsc2ffFoxD1GC mice had stunted growth with seizures and tail and hind limb tremor with a median survival of 110 days. They also showed recombination in brain, spinal cord, tongue, liver, intestine and skeletal muscle. Distinctive perivascular tumors consisting of cells with oval nuclei and scant cytoplasm were identified in multiple sites in all Tsc2ffFoxD1GC mice. Immunohistochemistry staining showed a high expression of phospho-S6-S240/244, a hallmark of activated mTORC1, as well as pericyte markers NG2 and vimentin in these tumors. In summary, we demonstrate that loss of Tsc2 in pericytes generates HPC, the first mouse model of HPC reported.

authors
author list (cited authors)
Du, H., Dreier, J. R., Zarei, M., Wu, C., Bronson, R. W., & Kwiatkowski, D. J.
publication date
2018
published in
keywords
  • Humans
  • Mice
  • Tuberous Sclerosis Complex 2 Protein
  • Vimentin
  • Disease Models, Animal
  • Hemangiopericytoma
  • Antigens
  • Proteoglycans
  • Mechanistic Target Of Rapamycin Complex 1
  • Animals
  • Integrases
  • Pericytes
  • Gene Expression Regulation, Neoplastic
  • Forkhead Transcription Factors
  • Seizures
altmetric score

0.25

citation count

1